Литература

Поставить закладку

WAO, White Book on Allergy, 2011-2012, p.13.
Лекарственная аллергия. Методические рекомендации для врачей. Под редакцией академика РАН и РАМН Р.М.Хаитова, 2012, Фармарус принт-медиа, с.73.
Demoly P., Adkinson N.F., Brockow K., Castells M. et al. International consensus on drug allergy. Allergy, 2014, v.69, p.420-437.
Mirakian R., Ewan P.W., Durham S.R., Yolten L.J.F. et al. BSACI guidelines for the management of drug allergy. Clin. And Exper. Allergy, 2008, v.39, p.43-61.
Solensky R., Khan D.A. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol., 2010, v.105(4), p.259-273.
Brockow K., Przybilla B., Aberer W., Bircher A.J. et al. Guideline for the diagnosis of drug hypersensitivity reactions. Allergo J Int., 2015, v.24, p.94-105.
Brockow K., Ardern-Jones M.R., Mockenhaupt M., Aberer W. et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy, 2019, v.74, p.14–27.
Романова Т.С. Особенности диагностики in vivo лекарственной аллергии, протекающей по замедленному типу. Дисс.к.м.н., 2018, с.190.
Panesar S, Javad S, de Silva D et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy, 2013, v.68(11), p.1353-1361.
Schvartz L.B., Min H.K., Ren S., Xia H.Z. et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by YMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol., 2003, v.170(11), p.5667-5673.
Cox L, Larenas-Linnemann D, Lockey R, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J of Allergy and Clin. Immunology. 2010, v.125(3), p.569574.
Valent P, Akin C, Arock M et al. Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal. Int Arch Allergy Immunol. 2012, v.157(3), p.215-225.
Mayorga C., Celic G., Rouzaire P., Whitaker P. et al. In vitro tests for drug hypersensitivity reactions. An ENDA/EAACI drug allergy interest group position paper. 2016, Allergy, v.71(8), p.1103-1134.
Simons R., Ardusso L., Bilo B. et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. WAO Position Paper, 2011, Feb., р.13-37.
Lieberman Р., Nicklas R., Oppenheime J., Kemp S. et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J.Allergy Clin. Immunol., v.126, Issue 3, 2010, Sept., p.477-480.
Laroche D, Gomis P, Gallimidi E, Malinovsky J, Mertes P. Diagnostic Value of Histamine and Tryptase Concentrations in Severe Anaphylaxis with Shock or Cardiac Arrest during Anesthesia. Anesthesiology. 2014, v.121(2), p.272-279.
Ильина Н.И., Латышева Т.В., Мясникова Т.Н. и др. Клинические рекомендации МЗ РФ. Анафилактический шок, 2020.
Barbaud A., Gonsalo M., Bruynzeel D., Bircher A. Guidelines for perfoming skin test with drugs in the investigation of cutaneous adverse drug reactions. 2001, Contact dermatitis, v.45, p.321-328.
Aberer V., Bircher F., Romano A., Blanca M. et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. 2003, Allergy, v.58, p.854-863.